A real-world study has found that during hospitalizations among people with von Willebrand disease (VWD), VWF replacement therapy with lab-made Veyvondi (vonicog alfa) is…
Von Willebrand disease
Von Willebrand disease is a genetic bleeding disorder that impairs the body’s ability to form proper blood clots. It can cause frequent or prolonged bleeding episodes, but many people experience only mild or manageable symptoms.
Treatment for von Willebrand disease focuses on preventing and controlling bleeding to improve daily life and reduce serious risks. Management plans vary by disease type and may involve ongoing monitoring and personalized care strategies.
Latest news
Preventive (prophylactic) treatment with Wilate reduced annual bleeding rates by more than 80% in people with von Willebrand disease (VWD) type 3, the…